Abstract:A high recurrence rate and easy metastasis are two prominent clinical features of hepatocellular carcinoma (HCC), which is also the most common cause of cancer-related death. However, the molecular pathogenesis of HCC remains unclear. Soluble resistance-related calcium-binding protein (Sorcin) is highly expressed in a variety of tumor cell lines and multidrug-resistant cell lines and participates in the malignant progression of tumors by regulating apoptosis. Pyroptosis is also a form of programmed cell death that plays a crucial role in exerting tumor suppression function and evoking anti-tumor immune responses. However, there is no consensus that Sorcin promotes HCC progression by regulating pyroptosis. Our study manifested that Sorcin was considerably upregulated, whereas pyroptosis-associated proteins were significantly decreased in HCC tissues and cells. Sorcin silencing attenuated the proliferation, migration, and invasion of HCC cells. Knockdown of Sorcin activates pyroptosis, and overexpression of Sorcin inhibits pyroptosis, yet has no significant effect on apoptosis, ferroptosis, and autophagy in HCC cells. Furthermore, coimmunoprecipitation and immunofluorescence assays revealed that Sorcin interacted with NLRP3 inflammasome to regulate pyroptosis in HCC cells. Then, the NLRP3 inhibitor MCC950 inhibited the activation of Sorcin knockdown-induced pyroptosis and reversed the effect of Sorcin silencing-induced weakening of malignant biological behavior in HCC. Similarly, suppression of Caspase-1 reversed the inhibitory effect of Sorcin knockdown on the malignant progression of HCC via knockdown of Caspase-1 or the inhibitor VX765. Consistent with the in vitro results, the nude mouse experiment showed that Sorcin knockdown inhibited the growth of HCC by activating pyroptosis, while Caspase-1 knockdown partially restored the growth inhibition caused by Sorcin knockdown. Collectively, high Sorcin expression in HCC negatively regulates pyroptosis by interacting with the NLRP3 inflammasome to promote HCC proliferation, migration, and invasion. The results of this study provide a scientific basis for Sorcin as a new biomarker and potential therapeutic target for HCC.

Soluble resistance-related calcium-binding protein participates in multiple diseases via protein-protein interactions

&Lt;p>sorcin: a Novel Potential Target in Therapies of Cancers</p>

Sorcin a Potential Molecular Target for Cancer Therapy

Sorcin in Cancer Development and Chemotherapeutic Drug Resistance

Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeutics

Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases

Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis.

Sorcin Enhances Metastasis and Promotes Epithelial-To-Mesenchymal Transition of Colorectal Cancer

Clinical Significance and Prognostic Value of Human Soluble Resistance-Related Calcium-Binding Protein: A Pan-Cancer Analysis

Overexpression of Sorcin Results in Multidrug Resistance in Gastric Cancer Cells with Up-Regulation of P-gp.

Negative Regulation of Hepatic Inflammation by the Soluble Resistance-Related Calcium-Binding Protein Signal Transducer and Activator of Transcription 3.

Overexpression of sorcin improves cardiac excitation-contraction coupling in normal and failing ventricular cardiomyocytes

Expression of a sorcin missense mutation in the heart modulates excitation-contraction coupling

Calcium-binding Protein S100P and Cancer: Mechanisms and Clinical Relevance

Sorcin regulate pyroptosis by interacting with NLRP3 inflammasomes to facilitate the progression of hepatocellular carcinoma

Regulation of Cardiac Excitation-Contraction Coupling by Sorcin, a Novel Modulator of Ryanodine Receptors

Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins

348P Up-regulation of Sorcin Promotes Glioblastoma Progression Via Activating the PI3K/AKT/mTOR Pathway

Sorcin Overexpression and Multidrug Resistance in Human Gastric Cancer Cells

The interaction protein of SORBS2 in myocardial tissue to find out the pathogenic mechanism of LVNC disease

A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer